who should not take glp-1 receptor agonists Overview of Available in the United States for GLP-1 medications like Ozempic are

to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events

Einordnung orientiert an offiziellen Stellen: BfArM (Arzneimittel in Deutschland), EMA (Zulassungen in der EU) und WADA-Verbotsliste (deutschsprachig bei der NADA)

Weiss FD, Calderon L, Wang YF, Georgieva R, Guo Y, Cvetesic N, et al

Keratin is a type of protein thats present in surface cells

Endocrinology, 159 ,

Vitamin Bt should not be used to treat serious carnitine deficiency since it can interfere with the body's use of levocarnitine